Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	5,867	5,239	3,104	3,261	8,144	1,692
Market Cap Growth	120.50%	68.80%	-4.84%	-59.96%	381.32%	-17.32%
Enterprise Value	6,321	6,325	4,110	3,952	8,399	1,846
Last Close Price	37.75	33.71	19.97	21.26	53.09	11.03
PS Ratio	11.36	10.14	4.78	6.43	24.69	4.66
PB Ratio	90.36	80.69	-126.49	7.88	13.59	2.34
P/TBV Ratio	139.35	124.44	-	15.00	14.43	2.50
P/FCF Ratio	-	-	189.81	-	-	-
P/OCF Ratio	-	-	21.95	-	-	48.11
EV/Sales Ratio	12.24	12.24	6.33	7.80	25.46	5.08
EV/EBITDA Ratio	-	557.77	-	-	-	92.74
EV/FCF Ratio	-40.81	-	251.38	-	-	-
Debt / Equity Ratio	7.82	7.82	-38.70	2.62	0.66	0.45
Debt / EBITDA Ratio	35.37	35.37	-	-	-	16.07
Debt / FCF Ratio	-	-	58.08	-	-	-
Net Debt / Equity Ratio	6.96	6.96	-37.69	2.42	0.62	0.31
Net Debt / EBITDA Ratio	39.85	39.85	-8.12	-8.17	-7.07	11.24
Net Debt / FCF Ratio	-2.92	-2.92	56.56	-1.54	-2.54	-0.69
Asset Turnover	0.46	0.46	0.38	0.32	0.26	0.33
Inventory Turnover	5.24	5.24	5.08	4.21	5.08	5.43
Quick Ratio	0.18	0.18	0.10	0.29	0.18	0.42
Current Ratio	0.35	0.35	0.17	0.51	1.04	0.58
Return on Equity (ROE)	-689.73%	-689.73%	-228.96%	-43.93%	-18.57%	-3.55%
Return on Assets (ROA)	-4.66%	-4.66%	-7.62%	-7.49%	-5.84%	-0.78%
Return on Invested Capital (ROIC)	-11.16%	-11.78%	-18.19%	-16.08%	-12.18%	-1.74%
Return on Capital Employed (ROCE)	-55.10%	-55.10%	-84.70%	-18.60%	-15.50%	-1.60%
Earnings Yield	-2.37%	-2.66%	-14.33%	-6.80%	-1.50%	-1.54%
FCF Yield	-2.64%	-2.96%	0.53%	-19.97%	-1.80%	-19.03%
Buyback Yield / Dilution	0.52%	0.52%	-0.98%	0.20%	-0.75%	0.72%
Total Shareholder Return	0.52%	0.52%	-0.98%	0.20%	-0.75%	0.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.